SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Holt Steven James

(Last)

(First)

(Middle)

7140 OFFICE CIRCLE

(Street)

EVANSVILLE

47715

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2007

3. Issuer Name and Ticker or Trading Symbol
ACCURIDE CORP [ ACW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Sr VP/Strategy, Growth & Tech.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
common stock	261	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
stock option (right to buy)	⁽¹⁾	04/26/2015	common stock	7,758	$9	D
stock option (right to buy)	⁽²⁾	04/26/2015	common stock	2,586	$9	D
Stock Appreciation Right	⁽³⁾	12/18/2016	common stock	9,688	$11.34	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common stock	3,366	⁽⁴⁾	D

Explanation of Responses:

1. 2,586 shares subject to the grant are fully exercisable. Subject to the recipient continuing to provide services to Accuride, 2,586 of the shares subject to the option will vest on December 31, 2007 and 2,586 of the shares subject to the option will vest on December 31, 2008.

2. On April 26, 2005, the reporting person was granted an option to purchase 10,342 shares of common stock. 2,586 shares subject to the grant are fully exercisable. 5,171 of the shares subject to the option remain unvested, and will vest in two equal installments (subject to adjustment for fractional shares) based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2007 and 2008 and the recipient's continued service to the company.

3. 100% of the shares subject to Stock Appreciation Right (the "SAR") will fully vest and become exercisable on December 31, 2009. Notwithstanding the foregoing, if certain future performance goals are met annually, 25% of the total number of shares subject to the SAR will fully vest and become exercisable on December 31, 2007 and December 31, 2008, respectively.

4. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Accuride stock. 748 of the total number of RSUs will vest on December 31, 2007, 1,122 of the RSUs will vest on December 31, 2008 and the remaining 1,496 of the RSUs will vest on December 31, 2009.

	/s/ Steven James Holt	03/08/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.